QV are delighted to announce that Dr Stephen Minger has joined the QV team in an advisory role.

Dr Stephen Minger is one of the pioneering researchers in human stem cell biology and regenerative medicine.  Over the past 25+ years, Stephen’s has been at the forefront of human gene therapy/stem cell research. In 2002, he was awarded one of the first two licenses by the UK Human Fertilisation and Embryology Authority (HFEA) for the derivation of human embryonic stem cells. He was one of the first two groups to be granted a research license by the HFEA in 2008 to pursue Somatic Cell Nuclear Transfer to generate “hybrid human embryos”.  From 2002-2009, he was the Director of the Stem Cell Biology Laboratory at King’s College London, and the Global Head of R&D and Chief Scientist for GE Healthcare Life Sciences from 2009-2015.  Stephen is the Founder/Director of SLM Blue Skies Innovations Ltd, providing expert analysis in emerging healthcare technologies for biotechnology companies and the investment community in gene/cell-based therapies, human tissue fabrication, implementation of robotics/synthetic intelligence, machine-brain interfaces, and human pluripotent stem cell technologies, amongst others.  He has a PhD in Neuroscience and Pathology from the Albert Einstein College of Medicine in New York City.

We are incredibly excited to be working with someone of Stephen’s calibre as we strive to deliver longer, better quality lives for brain tumour patients.